Rallybio Corp. (RLYB)
17.02
+0.14
(+0.86%)
USD |
NASDAQ |
Sep 14, 10:38
Rallybio Market Cap : 90.32M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 89.55M |
| September 10, 2026 | 88.89M |
| September 09, 2026 | 90.06M |
| September 08, 2026 | 88.15M |
| September 04, 2026 | 89.82M |
| September 03, 2026 | 89.55M |
| September 02, 2026 | 89.90M |
| September 01, 2026 | 88.57M |
| August 31, 2026 | 89.10M |
| August 28, 2026 | 89.21M |
| August 27, 2026 | 88.94M |
| August 26, 2026 | 89.58M |
| August 25, 2026 | 89.61M |
| August 24, 2026 | 89.16M |
| August 21, 2026 | 89.32M |
| August 20, 2026 | 88.09M |
| August 19, 2026 | 90.22M |
| August 18, 2026 | 89.00M |
| August 17, 2026 | 90.22M |
| August 14, 2026 | 90.16M |
| August 13, 2026 | 90.00M |
| August 12, 2026 | 88.04M |
| August 11, 2026 | 86.93M |
| August 10, 2026 | 88.15M |
| August 07, 2026 | 85.76M |
| Date | Value |
|---|---|
| August 06, 2026 | 85.92M |
| August 05, 2026 | 85.65M |
| August 04, 2026 | 84.70M |
| August 03, 2026 | 84.38M |
| July 31, 2026 | 84.27M |
| July 30, 2026 | 85.01M |
| July 29, 2026 | 84.43M |
| July 28, 2026 | 85.46M |
| July 27, 2026 | 86.28M |
| July 24, 2026 | 86.28M |
| July 23, 2026 | 86.71M |
| July 22, 2026 | 87.92M |
| July 21, 2026 | 89.46M |
| July 20, 2026 | 88.40M |
| July 17, 2026 | 86.87M |
| July 16, 2026 | 84.43M |
| July 15, 2026 | 85.33M |
| July 14, 2026 | 84.70M |
| July 13, 2026 | 84.06M |
| July 10, 2026 | 83.21M |
| July 09, 2026 | 83.74M |
| July 08, 2026 | 82.95M |
| July 07, 2026 | 82.90M |
| July 06, 2026 | 83.16M |
| July 02, 2026 | 83.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.513B |
| C4 Therapeutics, Inc. | 428.94M |
| Cullinan Therapeutics, Inc. | 1.274B |
| Q32 Bio, Inc. | 260.63M |
| Arrowhead Pharmaceuticals, Inc. | 11.54B |
Market Cap Related Metrics
| PE Ratio | 2.179 |
| PS Ratio | 147.56 |
| Price to Book Value | 0.9558 |
| Price to Free Cash Flow | 3.569 |
| Price | 17.02 |
| Earnings Yield | 45.90% |
| Normalized PE Ratio | 6.866 |